Godavari Biorefineries Ltd

Godavari Biorefineries Ltd has announced the approval of its United States patent application for "5-Hydroxy-1,4-Naphthalenedione for use in the treatment of cancer." This patent protects a novel class of compounds that effectively inhibit cancer and cancer stem cells, showing significant potential against various cancer types, including breast and prostate. The granted patent provides exclusive rights to the company in the US for making, using, offering for sale, or selling the invention for a specified term.

Godavari Biorefineries Ltd has announced that the Mexican Patent Office has granted its patent application titled 'Use of Compounds for Treating Viral Infections'. The patent pertains to the use of specific compounds for inhibiting V-ATPase activity, with applications in the manufacture of medicaments for treating viral infections. This grant, effective from September 15, 2026, provides protection for twenty years, expiring on May 10, 2041. The invention was originally filed internationally on May 10, 2021, with priority from an Indian application dated May 11, 2020. This intellectual property strengthens the company's position in the biopharmaceutical sector.

Godavari Biorefineries Ltd announced at its 71st Annual General Meeting (AGM) held on September 28, 2026, the re-appointment of Dr. Raman Ramachandran and Mr. Suhas Godage as Directors, liable to retire by rotation. The AGM also approved the re-appointment and remuneration for Mr. Samir S. Somaiya as Managing Director and Mr. Suhas Godage as Executive Director (Works-Sakarwadi), both effective April 1, 2027. Additionally, Mr. Dinesh Sharma was appointed as a Director and approved as Executive Director (Works-Sameerwadi) for three years, effective September 28, 2026. All appointed/re-appointed directors are confirmed not to be debarred by any SEBI order or other authority.

Godavari Biorefineries Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with SEBI's Insider Trading Regulations and the company's internal code. The window will be shut for all directors, key managerial persons, designated employees, and their immediate relatives. It commences on October 01, 2026, and will reopen 48 hours after the declaration of the unaudited financial results for the quarter and half-year ended September 30, 2026. The exact date for the financial results announcement will be communicated later.

Godavari Biorefineries Ltd has received a Demand Notice from the Assistant Executive Engineer (E) O & M Sub Division, HESCOM, Mahalingpur, Karnataka. The notice pertains to cross-subsidy charges for open access power imported between 2013 and 2016. The total demand is ₹12,88,27,935, comprising a principal amount of ₹5,90,95,383 and interest of ₹6,97,32,552. The company has recognized the principal amount as a contingent liability and is assessing the further impact and will take appropriate actions.

Godavari Biorefineries Ltd has announced that the Chinese Patent Office has granted its patent application titled "Use of Compounds for Treating Viral Infections." This patent covers the use of specific compounds for inhibiting V-ATPase activity in cells and their application in manufacturing medicaments for treating viral infections. The patent, with number ZL 2021 8 0048053.9, was granted on September 15, 2026, and is a significant development for the company's intellectual property portfolio in a key international market.

Godavari Biorefineries Ltd has announced that the European Patent Office has granted a patent for its invention titled "A Biofiller for Rubber Reinforcement". This biofiller is designed to be an efficient, economic, biodegradable, and eco-friendly alternative to conventional carbon black used in rubber products. The technology aims to partially replace carbon black in applications such as tires, footwear, belts, and other industrial rubber goods, while maintaining or enhancing mechanical properties. The invention includes a scalable manufacturing process and offers a strong value proposition by combining performance, cost savings, and environmental benefits.

Godavari Biorefineries Ltd has announced its 71st Annual General Meeting (AGM) scheduled for Monday, September 28, 2026, at 11:30 a.m. IST, to be held via Video Conferencing/Other Audio Visual Means. The company is submitting its Annual Report for the Financial Year 2025-26, which has been sent to eligible members via email on September 4, 2026. The report is also available on the company's website. The AGM will facilitate remote e-voting from September 25 to September 27, 2026, with a cut-off date of September 21, 2026, for members to be eligible to vote. The Annual Report details the company's corporate overview, financial statements, business segments, and commitment to sustainability.

Godavari Biorefineries Ltd has issued a notice regarding its 71st Annual General Meeting (AGM) scheduled for September 28, 2026, to be held via Video Conferencing. The company is also providing a web link to its Annual Report for the Financial Year 2025-26 for shareholders who have not registered their email addresses. This communication also serves as a reminder for shareholders holding physical securities to update their KYC details, including PAN, address, bank details, and nomination, as mandated by SEBI. Failure to update KYC may affect dividend and other payments, which will be processed electronically from April 1, 2024.

Godavari Biorefineries Limited has announced its 71st Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 11:30 a.m. IST. The meeting will be conducted entirely through Video Conferencing (VC) and Other Audio Visual Means (OAVM), adhering to the Companies Act, 2013, and SEBI Listing Regulations. Key agenda items include the adoption of audited financial statements for the fiscal year ending March 31, 2026 (both standalone and consolidated), the re-appointment of two directors retiring by rotation, Dr. Raman Ramachandran and Mr. Suhas Godage, and the approval of the re-appointment and remuneration terms for Mr. Samir S. Somaiya as Managing Director for a three-year period starting April 1, 2027. The proceedings will be deemed to be conducted at the company's registered office in Mumbai.